EU breast cancer research targets personalised treatment
Caption: The ASSURE project tailors breast cancer screening – hematoxylin and eosin marked breast tissue containing invasive ductal carcinoma.
Today, in most developed countries, one in eight women will likely develop breast cancer during their lifetime. Boosting support for early detection, more effective treatments and better palliative care has been the focus ofBreast Cancer Awareness Month this October. One promising avenue which a number of EU-funded research projects are taking is personalised medicine – adjusting treatment to a patient’s specific circumstances and condition.
From lab to clinic
The EU project TRANSBIG has been linking laboratory work more closely to treatment with 'translational' research, says scientific director Fatima Cardoso of the Champalimaud Clinical Center in Lisbon, Portugal.:“TRANSBIG contributed to tackling the fragmentation in breast cancer translational research by strengthening relationships between leading European researchers in the field. It has also led to the successful launch of what is viewed as one of Europe’s most innovative breast cancer trials of the past decade.”
The results of the trial, known as MINDACT, will be available in 2015. The trial is investigating whether genomic analysis can help physicians make better decisions on whether a patient can avoid chemotherapy after breast cancer surgery.
Clinical trials have shown that chemotherapy, while effective, can also lead to secondary cancers, damage to the heart, early menopause and reduced cognitive functions. And a substantial proportion of patients with early-stage breast cancer are thought to be over-treated, says Cardoso. MINDACT may avoid chemotherapy in 10 – 20 % of patients.
MINDACT has enrolled more than 6 600 women in 9 countries for the research, managed by the European Organisation for the Research and Treatment of Cancer (EORTC), and developed in collaboration with the Breast International Group (BIG), coordinator of TRANSBIG.
“Hundreds of thousands of women can benefit from translating research breakthroughs to life-saving treatments for breast cancer,” said EU Research, Innovation and Science Commissioner Máire Geoghegan-Quinn. “Cancer research has been a priority for EU research funding. Some €1.4 billion was devoted to translational cancer research from 2007 to 2013. We will continue that focus under Horizon 2020, speeding up the transfer of basic knowledge to early diagnosis, preventive and therapeutic approaches.”
Other EU research projects on breast cancer include EPIC, which studied how changes to a person’s diet could potentially prevent breast cancer. The CareMore and CTCTRAP projects are focusing on circulating tumour cells and DNA in a patient’s blood to guide early diagnosis and treatments for women with metastatic breast cancer. Meanwhile ASSURE is looking at ways to tailor breast cancer screening to an individual’s needs, and is developing alternatives to mammography – unsuitable for cancer detection in women with dense breasts.
Another project, RATHER, is identifying novel treatments, along with personalised diagnostic techniques, for women with triple-negative and invasive lobular breast cancer. These are difficult-to-treat cancers for which no targeted therapies are currently available. Finally, the MERIT project is developing a way to treat triple-negative breast cancers with personalised RNA vaccines that are unique to each patient.
Breast cancer remains the second most common cancer in the world, and kills more women than any other cancer type. In the EU, a record 364 449 women found out they had the disease in 2012. The EU invested €160 million in breast cancer research from 2007 to 2013 and that support will continue through Horizon 2020, the new research and innovation programme for 2014-2020.
On 1 January 2014, the European Union launched a new research and innovation funding programme called Horizon 2020. Over the next seven years almost €80 billion will be invested in research and innovation projects to support Europe’s economic competitiveness and extend the frontiers of human knowledge. The EU research budget is focused mainly on improving everyday life in areas like health, the environment, transport, food and energy.
For more information
BIG and TRANSBIG: www.BIGagainstbreastcancer.org
Horizon 2020 website: http://ec.europa.eu/programmes/horizon2020/
Monika Wcislo (+32 2 298 65 95)
For the public: Europe Direct by phone 00 800 6 7 8 9 10 11 or by email
Latest News from
Talent Partnerships: Commission launches new initiative to address EU skills shortages and improve migration cooperation with partner countries11/06/2021 16:33:00
Today, the Commission is launching Talent Partnerships, a key initiative under the New Pact on Migration and Asylum that will help to address skills shortages in the European Union and to strengthen mutually-beneficial partnerships on migration with third countries.
Central America and Mexico: EU reaffirms support with €18.5 million in humanitarian and development aid11/06/2021 15:25:00
The EU yesterday announced at the 'Solidarity event for forcibly displaced persons and host communities in Central America and Mexico', that it will allocate €18.5 million in aid. Of this sum, €12 million represents humanitarian funding to Central America, and €6.5 million constitutes development assistance.
Council endorses new EU strategy on adaptation to climate change11/06/2021 14:38:00
The Council yesterday approved conclusions endorsing a new strategy that outlines a long-term vision for the EU to become a climate-resilient society that is fully adapted to the unavoidable impacts of climate change by 2050.
Child Labour: Statement by the European Commission and the High Representative on the World Day against Child Labour11/06/2021 13:25:00
Child Labour: Statement given by the European Commission and the High Representative on the World Day against Child Labour.
Education: EU increases its commitment to Global Partnership for Education with a pledge of €700 million for 2021-202711/06/2021 12:38:00
Ahead of the G7 Summit, President of the European Commission Ursula von der Leyen yesterday announced that the European Union is pledging €700 million for the Global Partnership for Education (GPE) to help transform education systems for more than one billion girls and boys in up to 90 countries and territories.
EU external action budget: European Commission welcomes the final adoption of the EU's new long-term external action budget for 2021-202711/06/2021 11:33:00
The European Commission welcomes the European Parliament's decision to adopt the Neighbourhood, Development and International Cooperation Instrument (NDICI) – ‘Global Europe' for the period 2021-2027.
Speech by President von der Leyen at the European Parliament Plenary on the conclusions of the special meeting of the European Council of 24-25 May 2021 and preparation of the G7 Summit of 11-13 June 2021 and the EU-U.S. Summit11/06/2021 10:38:00
Speech given recently (09 June 2021) by President von der Leyen at the European Parliament Plenary on the conclusions of the special meeting of the European Council of 24-25 May 2021 and preparation of the G7 Summit of 11-13 June 2021 and the EU-U.S. Summit.
Report by President Charles Michel to the European Parliament plenary session11/06/2021 09:25:00
Hijacking a plane is piracy. With 171 passengers on board, it is kidnapping. When these acts are carried out by the state, it’s hostage-taking and state piracy.
Sustainable fisheries: Commission takes stock of progress in the EU and launches consultation on fishing opportunities for 202210/06/2021 16:33:00
The Commission yesterday adopted the Communication “Towards more sustainable fishing in the EU: state of play and orientations for 2022”.
EU citizens' electoral rights: Commission decides to refer CZECHIA and POLAND to the Court of Justice10/06/2021 15:25:00
The European Commission yesterday decided to refer Czechia and Poland to the Court of Justice, because in these two Member States EU citizens are restricted from joining a domestic political party.